Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Synteract acquired Cu-Tech a dermatology specialist CRO. The two companies have now created a dedicated center of dermatology development.
read more
PCI Pharma announced that Salim Haffar will join the company as Chief Executive Officer later this year.
read more
The Wasdell Group has launched its serialization service ahead of the EU FMD and US DSCSA implementation deadlines.
read more
SRI International announced a research agreement with Ionis, combining SRI's proprietary FOX Three Molecular Guidance cellular targeting system with Ionis' proprietary antisense drug-discovery platform.
read more
Highmark announced an outcomes-based contract with Boehringer Ingelheim for Jardiance, an oral medicine indicated to lower blood sugar in adults with type 2 diabetes.
read more
QIAGEN announced a partnership with multiple organizations to support creating a global genomics campus in Manchester, U.K.
read more
Catalent Pharma Solutions and Berkeley Lights announced Catalent Biologics will adopt BLI’s Beacon optofluidic platform to accelerate its cell line development workflow.
read more
908 Devices announced a joint innovation partnership with Hangzhou Just Biotherapeutics.
read more
TFF Pharmaceuticals announced the USPTO has issued a Notice of Allowance for U.S. Patent Application No. 12/778,795, "Compositions and Methods of Making Brittle-Matrix Particles Through Blister Pack Freezing."
read more
TrialScope has been selected by GlaxoSmithKline to facilitate clinical trial disclosure and transparency which amounts to disclosing more than 1,200 records per year from studies conducted in over 90 countries around the globe.
read more
Tocagen and ApolloBio announced the closing of an agreement providing ApolloBio with the exclusive right to develop and commercialize Toca 511 & Toca FC within the greater China region.
read more
Endocyte and ITM Isotopen Technologien München announced ITM´s subsidiary Endocyte have signed a long-term global supply agreement for Lutetium-177 EndolucinBeta to support clinical and commercial supply of 177Lu-PSMA-617.
read more
CluePoints has entered into an enterprise agreement with Japanese drug development organization, ONO Pharmaceutical.
read more
WuXi Biologics and Immune Pharmaceuticals announced a development and manufacturing agreement for the production of bertilimumab, Immune's first-in-class anti-eotaxin-1 monoclonal antibody.
read more
Glenmark Pharmaceuticals announced its subsidiary Glenmark Specialty has entered into an exclusive licensing agreement with Seqirus to commercialize Ryaltris in Australia and New Zealand.
read more